These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16946672)

  • 41. Ocular growth and refractive error development in premature infants with or without retinopathy of prematurity.
    Cook A; White S; Batterbury M; Clark D
    Invest Ophthalmol Vis Sci; 2008 Dec; 49(12):5199-207. PubMed ID: 19036998
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oxygen and retinopathy of prematurity.
    Sears NC; Sears JE
    Int Ophthalmol Clin; 2011; 51(1):17-31. PubMed ID: 21139475
    [No Abstract]   [Full Text] [Related]  

  • 43. Pathogenesis of retinopathy of prematurity and possible preventive strategies.
    Fleck BW; McIntosh N
    Early Hum Dev; 2008 Feb; 84(2):83-8. PubMed ID: 18234458
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mediators involved in retinopathy of prematurity and emerging therapeutic targets.
    Mataftsi A; Dimitrakos SA; Adams GG
    Early Hum Dev; 2011 Oct; 87(10):683-90. PubMed ID: 21700404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Prevalence and risk factors of retinopathy of prematurity].
    Huo DM; Dong FT; Dai RP; Chu J; Yu WH
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2006 Aug; 28(4):567-9. PubMed ID: 16995315
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Retinopathy of prematurity.
    Fulco E; Lira R
    Ophthalmology; 2010 Jun; 117(6):1282; author reply 1282-3. PubMed ID: 20522348
    [No Abstract]   [Full Text] [Related]  

  • 47. Published genetic variants in retinopathy of prematurity: random forest analysis suggests a negligible contribution to risk and severity.
    Dunai G; Vásárhelyi B; Szabó M; Hajdú J; Mészáros G; Tulassay T; Treszl A
    Curr Eye Res; 2008 May; 33(5):501-5. PubMed ID: 18568888
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update in the Treatment of Retinopathy of Prematurity.
    Bancalari A; Schade R
    Am J Perinatol; 2022 Jan; 39(1):22-30. PubMed ID: 32544962
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Progression and timing of treatment of zone I retinopathy of prematurity.
    Soh Y; Fujino T; Hatsukawa Y
    Am J Ophthalmol; 2008 Sep; 146(3):369-374. PubMed ID: 18602081
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Laser treatment for retinopathy of prematurity: evolution in treatment technique over 15 years.
    Hurley BR; McNamara JA; Fineman MS; Ho AC; Tasman W; Kaiser RS; Vander JF; Regillo CD; Brown GC
    Retina; 2006 Sep; 26(7 Suppl):S16-7. PubMed ID: 16946671
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Screening for retinopathy of prematurity: results of a 7-year study of underweight newborns.
    Flores-Santos R; Hernández-Cabrera MA; Henández-Herrera RJ; Sepúlveda-Cañamar F
    Arch Med Res; 2007 May; 38(4):440-3. PubMed ID: 17416292
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of low oxygen saturation limits on the ductus arteriosus in extremely low birth weight infants.
    Noori S; Patel D; Friedlich P; Siassi B; Seri I; Ramanathan R
    J Perinatol; 2009 Aug; 29(8):553-7. PubMed ID: 19461594
    [TBL] [Abstract][Full Text] [Related]  

  • 53. STOP-ROP results suggest selective use of supplemental oxygen for prethreshold ROP.
    Mills MD
    Arch Ophthalmol; 2000 Aug; 118(8):1121-2. PubMed ID: 10922210
    [No Abstract]   [Full Text] [Related]  

  • 54. [Recent advances in retinopathy of prematurity].
    Huo DM; Dong FT
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Feb; 26(1):83-7. PubMed ID: 15052783
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Plasmin enzyme-assisted vitrectomy for primary and reoperated eyes with stage 5 retinopathy of prematurity.
    Wu WC; Drenser KA; Lai M; Capone A; Trese MT
    Retina; 2008 Mar; 28(3 Suppl):S75-80. PubMed ID: 18317350
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of L-thyroxine supplementation in a neonatal rat model of ROP.
    Wren SM; Leske DA; Mutapcic L; Fautsch MP; Holmes JM
    Curr Eye Res; 2006; 31(7-8):669-74. PubMed ID: 16877275
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Retinopathy of prematurity - pathophysiologic mechanisms and new treatment options].
    Stahl A; Aisenbrey S; Krohne TU
    Klin Monbl Augenheilkd; 2012 Oct; 229(10):1024-9. PubMed ID: 22961043
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Maturation of rod function in preterm infants with and without retinopathy of prematurity.
    Hamilton R; Bradnam MS; Dudgeon J; Mactier H
    J Pediatr; 2008 Nov; 153(5):605-11. PubMed ID: 18621392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Chosen etiopathogenetic factors in formation and development of retinopathy of prematurity (ROP)].
    Moll A; Grałek M
    Klin Oczna; 2004; 106(3):360-3. PubMed ID: 15515326
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The early treatment for ROP (ETROP) randomized trial: study results and nursing care adaptations.
    Jones JG; MacKinnon B; Good WV; Hardy RJ; Dobson V; Palmer EA; Phelps DL; Quintos M; Tung B;
    Insight; 2005; 30(2):7-13. PubMed ID: 16134467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.